Clinical trials in Austria
7,836 studies list at least one site in Austria. 1,112 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Get an email when these change. Save the studies in Austria recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
Medical University of Vienna (999) · Medical University of Graz (435) · Novartis Pharmaceuticals (251) · Hoffmann-La Roche (203) · Bayer (171) · Medical University Innsbruck (169) · Boehringer Ingelheim (161) · AstraZeneca (142)
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting13
- Preventive Potential of Fluoride Sealants in Adolescent Orthodontic PatientsNov 10, 2026NCT07691879
- SENECA - Smart Therapies for Chronic PainNov 4, 2026NCT07628179
- Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)Oct 30, 2026NCT07497321
- ABCSG R07 Rectal Cancer RegistryOct 30, 2026NCT07780305
- Comparison of Mastectomy Expander TrialOct 29, 2026NCT07434648
Show 8 moreShow fewer
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- A Study of DS-3939a in Participants With Solid TumorsOct 28, 2026NCT07739966
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Oct 26, 2026NCT07476729
- Measurement Agreement Between IBP and NIBP During Induction of Anesthesia in High Risk PatientsOct 22, 2026NCT07870356
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLOct 20, 2026NCT07297914
- Edge-to-edge Mitral Valve Repair in ATTR-CMOct 16, 2026NCT06075823
- Cardiovascular Rehabilitation After Infrarenal Aortic Aneurysm RepairOct 15, 2026NCT07690046
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
First site in Austria23
- Preventive Potential of Fluoride Sealants in Adolescent Orthodontic PatientsNov 10, 2026NCT07691879
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenNov 9, 2026NCT07621809
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )Nov 6, 2026NCT07621718
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.Nov 3, 2026NCT07365319
- The NUVASCULAR HARBOR Occlusion Device EU StudyNov 2, 2026NCT07900464
Show 18 moreShow fewer
- INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)Oct 29, 2026NCT07429266
- Comparison of Mastectomy Expander TrialOct 29, 2026NCT07434648
- A Study of DS-3939a in Participants With Solid TumorsOct 28, 2026NCT07739966
- A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia AOct 26, 2026NCT07416526
- VRAS (Velys Robot-Assisted Solution) Operational Excellence StudyOct 23, 2026NCT06563843
- An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 23, 2026NCT07184996
- Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.Oct 23, 2026NCT07480395
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseOct 21, 2026NCT07184944
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDOct 19, 2026NCT07652294
- Edge-to-edge Mitral Valve Repair in ATTR-CMOct 16, 2026NCT06075823
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerOct 16, 2026NCT06340568
- A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisOct 16, 2026NCT07185009
- Cardiovascular Rehabilitation After Infrarenal Aortic Aneurysm RepairOct 15, 2026NCT07690046
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
- Phase 3 Trial of Reltodecacog Alfa (VMX-C001) vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.Oct 14, 2026NCT07288489
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's DiseaseOct 14, 2026NCT07577843
- An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal PolypsOct 13, 2026NCT07424144
- A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative ColitisOct 13, 2026NCT07577856
Results posted14
- Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCNov 10, 2026NCT03792841
- A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung CancerNov 9, 2026NCT04294810
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Nov 4, 2026NCT04720157
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
Show 9 moreShow fewer
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)Oct 29, 2026NCT00662740
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2Oct 27, 2026NCT05737940
- A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsOct 22, 2026NCT04420884
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)Oct 16, 2026NCT03310125
- Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or BladderOct 14, 2026NCT05512377
- Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLOct 13, 2026NCT06679582
Stopped5
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaWithdrawnOct 30, 2026NCT07084831
- Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 WeeksTerminatedOct 23, 2026NCT02051218
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedOct 21, 2026NCT06867094
- PREMEDICAL is a Clinical Investigation Aiming to Create a Data Basis That Can be Used to Enrich Information Collected in the Course of the Classic Patient Journey. Patients in the Emergency Department Will be Asked to Answer Patient-related and Symptom-oriented Questions. Minimum Age is 18 YearsTerminatedOct 21, 2026NCT06933550
- Trastuzumab + Alpelisib +/- Fulvestrant vs Trastuzumab + CT in PIK3CA-mutated HER2+ Advanced BC (ALPHABET)TerminatedOct 15, 2026NCT05063786
Newly registered30
- Targeted Minimally-Invasive Glaucoma SurgeryNov 10, 2026NCT07927803
- Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart FailureNov 10, 2026NCT07929467
- Clinical Study on the Safety and the Performance of an Endometrial Ablation System in Women With Abnormal Uterine Bleeding (AUB) and Previous Cesarean Delivery.Nov 9, 2026NCT07925008
- Rotational Stability of the Acunex Vario ToricNov 9, 2026NCT07925840
- Effect of Probiotics on Insulin Sensitivity in Overweight and Obese PregnancyNov 6, 2026NCT07921940
Show 25 moreShow fewer
- Preoperative Capsaicin Patch Treatment to Reduce Pain and Pain Sensitivity After SurgeryNov 6, 2026NCT07922525
- A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With R-(Mini)-CHOP for Treatment of Patients With DLBCL-type Richter TransformationNov 5, 2026NCT07917780
- Personalized Dietary Feedback to Reduce Hepatic Steatosis in Patients With MASLDNov 4, 2026NCT07914829
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
- Prospective Multicenter Cohort Study of Clinical and Molecular Biomarkers in Colorectal CancerNov 3, 2026NCT07913802
- Steatotic Liver Disease in Austria - Prospective Registry With BiobankNov 3, 2026NCT07914582
- CATCH AF - Atrial Fibrillation Detection in Cryptogenic StrokeOct 28, 2026NCT07899788
- Establishment of a Novel Flow Cytometric Diagnostic Assay to Effectively Evaluate Immune Reconstitution After Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic LeukemiaOct 28, 2026NCT07899840
- The NUVASCULAR HARBOR Occlusion Device EU StudyOct 28, 2026NCT07900464
- Use of Bioresorbable Magnesium Set Screws in Syndesmotic Injuries: a Pilot StudyOct 28, 2026NCT07901205
- Phase 1 Study to Evaluate RG002C0106 Injection in Healthy ParticipantsOct 28, 2026NCT07902245
- Mi2000 TICI Follow-upOct 28, 2026NCT07902414
- Real-World Study of Mirvetuximab Soravtansine in Adult Participants With Platinum-Resistant FRα-Positive Ovarian, Fallopian Tube, and Peritoneal CancerOct 27, 2026NCT07896421
- Effects of Ashwagandha Supplementation on Quality of Life and Well-Being in Women With EndometriosisOct 27, 2026NCT07898670
- Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary ProceduresOct 22, 2026NCT07888738
- Hand Grip Strength Correlates Strongly With Weekly Working Hours - the Importance of Upper Limb Function in Multiple SclerosisOct 22, 2026NCT07889271
- Cookies for PlateletsOct 22, 2026NCT07890467
- Outcome Prediction and Recovery After Spontaneous Intracerebral HaemorrhageOct 20, 2026NCT07882784
- Haptic-Assisted Virtual Reality Upper-Limb Rehabilitation After Intracerebral HaemorrhageOct 20, 2026NCT07882810
- Buccal Periosteal Inversion Flap vs Buccal Advancement Flap for Acute Oro-Antral Communication ClosureOct 20, 2026NCT07884331
- Double Transseptal Guide Sheath to Prevent Dock Drop During SAPIEN M3 Transcatheter Mitral Valve ReplacementOct 16, 2026NCT07878195
- Effectiveness of the "Aktivplan" Digital Intervention for Supporting Regular Heart-Healthy Physical Activity Following Phase II Cardiac RehabilitationOct 16, 2026NCT07878520
- BrainProtect-guided, Real-time Cerebral Autoregulation Monitoring and Protection of Brain During Cardiac Surgery With Cardiopulmonary Bypass Requiring Heart-lung MachineOct 14, 2026NCT07872982
- Measurement Agreement Between IBP and NIBP During Induction of Anesthesia in High Risk PatientsOct 13, 2026NCT07870356
- Safety of Sedation During Interventional EndoscopyOct 13, 2026NCT07872657
Studies
Recruiting first, then most recently updated. Showing 50 of 7,836 — search for more.
- Leadless Versus Conventional Pacemakers: Effects on Heart Function and Heart FailureNot yet recruitingNCT07929467Not applicable
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingNCT06646276Phase 3
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaRecruitingNCT05562466Phase 3
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)RecruitingNCT06345729Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)RecruitingNCT06824467Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)RecruitingNCT06997588Phase 2
- Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued TreatmentRecruitingNCT07444567Phase 3
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingNCT07291037Phase 3
- Preventive Potential of Fluoride Sealants in Adolescent Orthodontic PatientsRecruitingNCT07691879
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)RecruitingNCT07222488Phase 1/2
- A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)RecruitingNCT07190248Phase 3
- A Study to Evaluate Atumelnant in Adults With Congenital Adrenal HyperplasiaRecruitingNCT07144163Phase 3
- A Study of DS-3939a in Participants With Solid TumorsRecruitingNCT07739966Phase 1/2
- A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)RecruitingNCT07318558Phase 3
- Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBDEnrolling by invitationNCT07652294Phase 2
- Asciminib Roll-over StudyRecruitingNCT04877522Phase 4
- A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%RecruitingNCT06561386Phase 3
- A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma GangrenosumRecruitingNCT06624670Phase 3
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenRecruitingNCT07621809Phase 3
- A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDPRecruitingNCT07091630Phase 3
- Rotational Stability of the Acunex Vario ToricRecruitingNCT07925840Not applicable
- Clinical Study on the Safety and the Performance of an Endometrial Ablation System in Women With Abnormal Uterine Bleeding (AUB) and Previous Cesarean Delivery.RecruitingNCT07925008Not applicable
- International Pilot Study for Dual Non-invasive Assesment of Embryo DevelopmentRecruitingNCT06524648
- A Study to Evaluate the Benefit of Adding Durvalumab After Chemotherapy, Durvalumab and Surgery in Patients With Early-stage, Operable, Non-small Cell Lung Cancer.RecruitingNCT06284317Phase 3
- Pan Tumor Rollover StudyRecruitingNCT03899155Phase 2
- Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration SystemRecruitingNCT04798261
- A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDRecruitingNCT06847542Phase 3
- A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)RecruitingNCT05920356Phase 3
- A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With AdzynmaRecruitingNCT07353099
- InRAD Observational StudyRecruitingNCT07213700
- Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)RecruitingNCT07223814Phase 3
- A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking RuxolitinibRecruitingNCT07623161Phase 3
- A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical PracticeRecruitingNCT07284121
- Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )RecruitingNCT07621718Phase 3
- A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RecruitingNCT07216703Phase 3
- Dietary Intervention Study on Liver Health in Young AdultsRecruitingNCT07786831Not applicable
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)RecruitingNCT06393374Phase 3
- A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic AtrophyRecruitingNCT06541704Phase 3
- Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsRecruitingNCT06779630Not applicable